Kurokawa Yuji | Biological Safety Research Center National Institute Of Health Science
スポンサーリンク
概要
関連著者
-
Kurokawa Yuji
Biological Safety Research Center National Institute Of Health Sciences
-
Kurokawa Yuji
Biological Safety Research Center National Institute Of Health Science
-
Kitamura Y
Division Of Pathology National Institute Of Health Sciences
-
MATSUZAWA Toshiaki
Safety Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Kodama Yukio
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Matsuzawa Toshiaki
Safety Research Laboratories Of Yamanouchi Pharmaceutical Co. Ltd.
-
KUROKAWA Yuji
Biological Safety Research Center, National Institute of Health Sciences
-
Umemura T
Division Of Pathology National Institute Of Health Sciences
-
Kitajima Satoshi
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Satoh Kanako
東京都健康安全研究センター 環境保健部
-
Sai-kato Kimie
Division Of Toxicology
-
Hirabayashi Yoko
Division Of Cellular And Molecular Toxicology Kangwon National University
-
Hayashi Y
National Inst. Health Sci. Tokyo
-
Hayashi Yuzo
Department Of Pharmaceutical Sciences Kitasato University
-
KAWASAKI Yasushi
Div of Cellular and Molecular Toxicology
-
Sekita Kiyoshi
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
TANAKA Satoru
Toxicology Laboratory, Kissei Pharmaceutical Co., Ltd.
-
Kurokawa Y
Division Of Toxicology National Institute Of Health Sciences
-
Ono Atsushi
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
Ono Atsushi
Biological Safety Research Center National Institute Of Health Science
-
Nomura Mamoru
イナリサーチ
-
Nakamura Miho
Drug Safety Research Laoboratory Daiichi Pharmaceutical Co. Ltd.
-
Nomura M
Clinical Pathology Working Group The Japan Pharmaceutical Manufacturers Association
-
Nomura Mamoru
Drug Safety Research Laboratory Dai-ichi Pharmaceutical Co.ltd.
-
Kurokawa Yuji
Biological Safety Research Center National Institution Of Health Sciences
-
Akaike Masashi
Drug Development Research Laboratories Pharma Research And Development Division Hoechst Japan Limite
-
Akaike Masashi
Pharma Research And Development Division Drug Development Research Laboratories Hoechst Japan Limite
-
Kitaura K
Univ. Tokushima School Of Medicine Tokushima
-
HAYASHI Yuzo
Biological Safety Research Center, National Institute of Health Sciences
-
KAWASHIMA Kunio
National Institute of Health Sciences
-
KAWASHIMA Kunio
Biological Safety Research Center, National Institute of Health Sciences
-
Hayashi Y
Division Of Pathology National Institute Of Health Sciences
-
Takayama Satoshi
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
Tanaka Satoru
Division Of Pharmacology National Institute Of Hygienic Sciences
-
HAYASHI Yutaka
Clinical Pathology Working Group, the Japan Pharmaceutical Manufacturers Association
-
NOMURA Mamoru
Clinical Pathology Working Group, the Japan Pharmaceutical Manufacturers Association
-
UNNO Takashi
Clinical Pathology Working Group, the Japan Pharmaceutical Manufacturers Association
-
IGARASHI Toshiji
Clinical Pathology Working Group, the Japan Pharmaceutical Manufacturers Association
-
FURUYA Tsuyoshi
Biological Safety Research Center, National Institute of Health Science
-
SEKITA Kiyoshi
Biological Safety Research Center, National Institute of Health Science
-
Unno Takashi
Division Of Pathology National Institute Of Health Sciences
-
Umemura T
Hokkaido Univ. Sapporo Jpn
-
Hayashi Y
Department Of Pharmaceutical Sciences Kitasato University
-
Kurokawa Y
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Kodama Y
Biological Safety Research Center National Institute Of Health Science
-
Oguri Kazuta
Faculty Of Pharmaceutical Sciences Kyushu University
-
Unno Takashi
Japan Pharmaceutical Manufactures Association (jpma):kanebo Ltd
-
Hayashi Y
Department Of Pathology Tokyo Metropolitan Komagome Hospital
-
Tanaka S
Toxicology Laboratory Kissei Pharmaceutical Co. Ltd.
-
Kuroiwa Yuichi
Division Of Pathology National Institute Of Health Sciences
-
IGARASHI Toshiji
Eisai Co., Ltd.
-
Kobayashi Kazuo
National Institute Of Health Sciences
-
Igarashi T
Eisai Co. Ltd. Ibaraki Jpn
-
Kawasaki Yasushi
Div.of Toxicol. National Institute Of Health Sciences
-
Kawashima Kunio
Biological Safety Research Center National Institute Of Health Sciences
-
TAKAHASHI Michihito
Biological Safety Research Center, National Institute of Health Sciences
-
Matsuzawa T
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma)
-
Furuya Tsuyoshi
Biological Safety Research Center National Institute Of Health Science
-
Nakamura Miho
Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
NAKANIWA Hiroshi
Pharmaceutical Affairs Bureau, Ministry of Health and Welfare
-
Igarashi Toshiji
Eisai Co. Ltd.
-
Igarashi Toshiji
Eisai Co. Ltd. Tokyo Research Laboratories
-
Nakaniwa Hiroshi
Pharmaceutical Affairs Bureau Ministry Of Health And Welfare
-
Nomura Mamoru
Japan Pharmaceutical Manufactures Association (jpma):daiichi Pharmaceuticals Co.ltd
-
Unno Takashi
Clinical Pathology Working Group The Japan Pharmaceutical Manufacturers Association
-
Sekita Kiyoshi
Biological Safety Research Center National Institute Of Health Science
-
Igarashi Toshiji
Clinical Pathology Working Group The Japan Pharmaceutical Manufacturers Association
-
Umemura Takashi
Laboratory Of Comparative Pathology Graduate School Of Veterinary Medicine Hokkaido University
-
Takayama Satoshi
Research Department Saitama Daiichi Pharmaceutical Co. Ltd. Japanese Pharmaceutical Manufacturers As
-
Kobayashi Kazuo
Dept.of Toxicol.tokushima Res.inst.otsuka Pharmaceutical Co. Ltd.
-
Hayashi Yuzo
Biological Safety Research Center National Institute Of Hygienic Sciences
-
Takayama Satoshi
Research Department Saitama Daiichi Pharmaceutical Co. Ltd. Japanese Pharmaceutical Manufacturers Association
著作論文
- A SURVEY OF THE VALUES OF CLINICAL CHEMISTRY PARAMETERS OBTAINED FOR A COMMON RAT BLOOD SAMPLE IN NINETY-EIGHT JAPANESE LABORATORIES
- STUDIES ON THE OPTIMAL TREATMENT PERIOD AND PARAMETERS FOR DETECTION OF MALE FERTILITY DISORDER IN RATS : INTRODUCTORY SUMMARY (<SPECIAL ISSUE>TESTICULAR TOXICITY)
- Se2-1 Overview on the ICH(Proceedings of the 27th Annual Meeting)
- OPENING REMARKS(PROGRESS IN THE INTERNATIONAL HARMONISATION OF TOXICOLOGICAL TESTS AND SUBJECTS TO BE CONSIDERED FOR ITS IMPLEMENTATION)
- INTRODUCTORY REMARKS (Single Dose Toxicity and Repeated Dose Toxicity Studies)
- CURRENT STATUS OF THE INTERNATIONAL TOXICOLOGY GUIDELINES, FOCUSING ON THE OECD AND ICH GUIDELINES